RxSight is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. Co.'s proprietary RxSight Light Adjustable Lens system, comprised of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the first commercially available intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Co.'s LAL is made of proprietary photosensitive material that changes shape in response to specific patterns of ultraviolet light generated by Co.'s LDD. We show 10 historical shares outstanding datapoints in our RXST shares outstanding history coverage, used to compute RXST market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing RXST market cap history over the course of time is important for investors
interested in comparing RXST's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of RXST versus a peer is one thing; comparing
RXST market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like RXST can fluctuate over the course of history.
With this page we aim to empower investors researching RXST by allowing them to research the RXST market cap history. |
Free RXST Email Alerts:
Video: The Importance of Market Cap
